Literature DB >> 24186210

Cardiomyocyte Ogt is essential for postnatal viability.

Lewis J Watson1, Bethany W Long, Angelica M DeMartino, Kenneth R Brittian, Ryan D Readnower, Robert E Brainard, Timothy D Cummins, Lakshmanan Annamalai, Bradford G Hill, Steven P Jones.   

Abstract

The singly coded gene O-linked-β-N-acetylglucosamine (O-GlcNAc) transferase (Ogt) resides on the X chromosome and is necessary for embryonic stem cell viability during embryogenesis. In mature cells, this enzyme catalyzes the posttranslational modification known as O-GlcNAc to various cellular proteins. Several groups, including our own, have shown that acute increases in protein O-GlcNAcylation are cardioprotective both in vitro and in vivo. Yet, little is known about how OGT affects cardiac function because total body knockout (KO) animals are not viable. Presently, we sought to establish the potential involvement of cardiomyocyte Ogt in cardiac maturation. Initially, we characterized a constitutive cardiomyocyte-specific (cm)OGT KO (c-cmOGT KO) mouse and found that only 12% of the c-cmOGT KO mice survived to weaning age (4 wk old); the surviving animals were smaller than their wild-type littermates, had dilated hearts, and showed overt signs of heart failure. Dysfunctional c-cmOGT KO hearts were more fibrotic, apoptotic, and hypertrophic. Several glycolytic genes were also upregulated; however, there were no gross changes in mitochondrial O2 consumption. Histopathology of the KO hearts indicated the potential involvement of endoplasmic reticulum stress, directing us to evaluate expression of 78-kDa glucose-regulated protein and protein disulfide isomerase, which were elevated. Additional groups of mice were subjected to inducible deletion of cmOGT, which did not produce overt dysfunction within the first couple of weeks of deletion. Yet, long-term loss (via inducible deletion) of cmOGT produced gradual and progressive cardiomyopathy. Thus, cardiomyocyte Ogt is necessary for maturation of the mammalian heart, and inducible deletion of cmOGT in the adult mouse produces progressive ventricular dysfunction.

Entities:  

Keywords:  O-linked-β-N-acetylglucosamine transferase; cardiac function; hypertrophy; metabolism; remodeling; uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase

Mesh:

Substances:

Year:  2013        PMID: 24186210      PMCID: PMC3920156          DOI: 10.1152/ajpheart.00438.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

1.  O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.

Authors:  Lewis J Watson; Heberty T Facundo; Gladys A Ngoh; Mohamed Ameen; Robert E Brainard; Kewakebt M Lemma; Bethany W Long; Sumanth D Prabhu; Yu-Ting Xuan; Steven P Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose.

Authors:  Michael P Housley; Namrata D Udeshi; Joseph T Rodgers; Jeffrey Shabanowitz; Pere Puigserver; Donald F Hunt; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

3.  Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.

Authors:  Susan A Marsh; Louis J Dell'Italia; John C Chatham
Journal:  Amino Acids       Date:  2010-07-30       Impact factor: 3.520

4.  Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury.

Authors:  So-Young Hwang; Joo-Hyun Shin; Ji-Sun Hwang; Song-Yi Kim; Jin-A Shin; Eok-Soo Oh; Seikwan Oh; Jung-Bin Kim; Ja-Kyung Lee; Inn-Oc Han
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 5.  O-GlcNAc signaling in the cardiovascular system.

Authors:  Gladys A Ngoh; Heberty T Facundo; Ayesha Zafir; Steven P Jones
Journal:  Circ Res       Date:  2010-07-23       Impact factor: 17.367

Review 6.  O-GlcNAc signaling: a metabolic link between diabetes and cancer?

Authors:  C Slawson; R J Copeland; G W Hart
Journal:  Trends Biochem Sci       Date:  2010-05-11       Impact factor: 13.807

7.  Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.

Authors:  S A Caldwell; S R Jackson; K S Shahriari; T P Lynch; G Sethi; S Walker; K Vosseller; M J Reginato
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

8.  Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

Authors:  Tariq Hamid; Shang Z Guo; Justin R Kingery; Xilin Xiang; Buddhadeb Dawn; Sumanth D Prabhu
Journal:  Cardiovasc Res       Date:  2010-08-25       Impact factor: 10.787

9.  Increased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes.

Authors:  Kyoungsook Park; Christopher D Saudek; Gerald W Hart
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

10.  O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.

Authors:  Gladys A Ngoh; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

View more
  36 in total

1.  E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.

Authors:  Sujith Dassanayaka; Kenneth R Brittian; Andrea Jurkovic; Lauren A Higgins; Timothy N Audam; Bethany W Long; Linda T Harrison; Giuseppe Militello; Daniel W Riggs; Mitali G Chitre; Shizuka Uchida; Senthilkumar Muthusamy; Anna M Gumpert; Steven P Jones
Journal:  Basic Res Cardiol       Date:  2019-05-31       Impact factor: 17.165

Review 2.  Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).

Authors:  Natasha E Zachara
Journal:  FEBS Lett       Date:  2018-11-24       Impact factor: 4.124

3.  MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression.

Authors:  Senthilkumar Muthusamy; Angelica M DeMartino; Lewis J Watson; Kenneth R Brittian; Ayesha Zafir; Sujith Dassanayaka; Kyung U Hong; Steven P Jones
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

4.  Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.

Authors:  Sujith Dassanayaka; Robert E Brainard; Lewis J Watson; Bethany W Long; Kenneth R Brittian; Angelica M DeMartino; Allison L Aird; Anna M Gumpert; Timothy N Audam; Peter J Kilfoil; Senthilkumar Muthusamy; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Basic Res Cardiol       Date:  2017-03-15       Impact factor: 17.165

5.  Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.

Authors:  Shogo Ida; Katsutaro Morino; Osamu Sekine; Natsuko Ohashi; Shinji Kume; Tokuhiro Chano; Kanako Iwasaki; Norio Harada; Nobuya Inagaki; Satoshi Ugi; Hiroshi Maegawa
Journal:  Diabetologia       Date:  2017-06-22       Impact factor: 10.122

Review 6.  The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts.

Authors:  Heidi M Medford; Susan A Marsh
Journal:  Future Cardiol       Date:  2014-11

7.  Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca2+ channel activity and excitation-contraction coupling.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  Basic Res Cardiol       Date:  2020-09-10       Impact factor: 17.165

8.  A small molecule that inhibits OGT activity in cells.

Authors:  Rodrigo F Ortiz-Meoz; Jiaoyang Jiang; Michael B Lazarus; Marina Orman; John Janetzko; Chenguang Fan; Damien Y Duveau; Zhi-Wei Tan; Craig J Thomas; Suzanne Walker
Journal:  ACS Chem Biol       Date:  2015-03-18       Impact factor: 5.100

9.  O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.

Authors:  Ayako Makino; Anzhi Dai; Ying Han; Katia D Youssef; Weihua Wang; Reshma Donthamsetty; Brian T Scott; Hong Wang; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-12       Impact factor: 4.249

Review 10.  O-GlcNAcylation and cardiovascular disease.

Authors:  JaLessa N Wright; Helen E Collins; Adam R Wende; John C Chatham
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.